UroGen Pharma Ltd. - (URGN) share price
UroGen Pharma Ltd. - (NASDAQ:URGN) last traded at $24.75, down 3.81% on the day (quote 2026-11-06 21:00 UTC), with a market cap of $1.21B and a 52-week range of $16.5 to $50.81.
| Exchange | NASDAQ |
|---|---|
| Currency | USD |
| Last price | $24.75 |
| 1-day move | -3.81% |
| 52-week range | $16.5 - $50.81 |
| Market cap | $1.21B |
| From 52-week high | -51.30% |
| Volume vs average | 1.7x |
| Falling Shares risk score | 34/100 (ELEVATED) |
| Country | United States |
Frequently asked questions
Why is UroGen Pharma Ltd. - falling today?
UroGen Pharma Ltd. - (NASDAQ:URGN) is down 3.81% at its latest quote and trades 51.3% below its 52-week high, on volume 1.7x its average. A price fall alone does not identify a cause: Falling Shares Intelligence links a move to a filing, order or news item only when a source supports it.
What is the UroGen Pharma Ltd. - share price today?
UroGen Pharma Ltd. - (NASDAQ:URGN) last traded at $24.75, a -3.81% move on the day as of 2026-11-06 21:00 UTC. Market data comes from public feeds and may be delayed; it is not investment advice.
What is the 52-week range of UroGen Pharma Ltd. -?
UroGen Pharma Ltd. -'s 52-week low is $16.5 and its 52-week high is $50.81; the shares trade 51.3% below the high.
What is the market cap of UroGen Pharma Ltd. -?
UroGen Pharma Ltd. - has a market capitalisation of about $1.21B at the latest price.
What are the risks of investing in UroGen Pharma Ltd. -?
Falling Shares Intelligence rates UroGen Pharma Ltd. - 34/100 (ELEVATED) on price stress, volume and disclosure signals. Risk scores are analytical indicators, not allegations or investment advice. Review exchange filings and the company's own disclosures before any decision.
Data is compiled from public exchange feeds and may be delayed. Not investment advice.
Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com